Literature DB >> 34861339

Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018.

Natalia I Heredia1, Xiaotao Zhang2, Maya Balakrishnan3, Carrie R Daniel2, Jessica P Hwang4, Lorna H McNeill5, Aaron P Thrift6.   

Abstract

The association of physical activity (PA) and diet quality with non-alcoholic fatty liver disease (NAFLD) and NAFLD-related fibrosis have never been examined in a representative sample of U.S. adults using a more precise form of measuring NAFLD. The purpose of this study was to assess the associations of PA and diet quality (Healthy Eating Index [HEI]-2015) with NAFLD and a subset with advanced fibrosis (F3-4) as assessed by vibration-controlled transient elastography with controlled attenuation parameter in a representative sample of U.S. adults. This cross-sectional analysis uses data from 2017-2018 National Health and Nutrition Examination Survey. NAFLD was defined as controlled attenuation parameter ≥285 dB/m, and high likelihood of advanced fibrosis as liver stiffness measurements ≥8.6 kPa. Associations of HEI-2015 from 24-h dietary recalls and self-reported PA and sedentary behavior were estimated in multivariable-adjusted logistic regression models of NAFLD and advanced fibrosis. In 2892 adults, the prevalence of NAFLD and advanced fibrosis was 35.6% and 5.6%, respectively. We found that high adherence to U.S. dietary recommendations (highest vs. lowest HEI-2015 tertile) and more PA (middle tertile vs. lowest) were associated with reduced odds of NAFLD (Adjusted OR and 95% CI; 0.60 (0.44, 0.84) and 0.65 (0.42, 0.99), respectively). More PA was inversely associated with advanced fibrosis (Adjusted OR = 0.35, 95%CI 0.16, 0.75). Diet quality and PA are associated with reduced odds of NAFLD, and PA may be critical even for those with advanced liver disease. These behaviors should be the focus of targeted public health interventions.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced fibrosis; Diet; Diet quality; Fatty liver; Fibroscan; Fibrosis; Health Eating Index; National health and nutrition examination survey; Non-alcoholic fatty liver disease; Physical activity; Sedentary behavior; Transient Elastography

Mesh:

Year:  2021        PMID: 34861339      PMCID: PMC8724407          DOI: 10.1016/j.ypmed.2021.106903

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  40 in total

1.  Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

Authors:  Zobair M Younossi; Munkhzul Otgonsuren; Linda Henry; Chapy Venkatesan; Alita Mishra; Madeline Erario; Sharon Hunt
Journal:  Hepatology       Date:  2015-10-24       Impact factor: 17.425

Review 2.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

3.  The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.

Authors:  Raxitkumar Jinjuvadia; Fadi Antaki; Prateek Lohia; Suthat Liangpunsakul
Journal:  J Clin Gastroenterol       Date:  2017-02       Impact factor: 3.062

4.  Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease.

Authors:  Donghee Kim; Luis Miguel Vazquez-Montesino; Andrew A Li; George Cholankeril; Aijaz Ahmed
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.425

Review 5.  Nonalcoholic fatty liver disease: a systematic review.

Authors:  Mary E Rinella
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

Review 6.  Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.

Authors:  Guangqin Xiao; Sixian Zhu; Xiao Xiao; Lunan Yan; Jiayin Yang; Gang Wu
Journal:  Hepatology       Date:  2017-09-26       Impact factor: 17.425

Review 7.  Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.

Authors:  Shira Zelber-Sagi; Vlad Ratziu; Ran Oren
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

8.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

9.  Evaluation of the Healthy Eating Index-2015.

Authors:  Jill Reedy; Jennifer L Lerman; Susan M Krebs-Smith; Sharon I Kirkpatrick; TusaRebecca E Pannucci; Magdalena M Wilson; Amy F Subar; Lisa L Kahle; Janet A Tooze
Journal:  J Acad Nutr Diet       Date:  2018-09       Impact factor: 4.910

10.  Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort.

Authors:  Song-Yi Park; Mazen Noureddin; Carol Boushey; Lynne R Wilkens; Veronica W Setiawan
Journal:  Curr Dev Nutr       Date:  2020-02-20
View more
  3 in total

1.  Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S.

Authors:  Natalia I Heredia; Xiaotao Zhang; Maya Balakrishnan; Jessica P Hwang; Aaron P Thrift
Journal:  Ethn Health       Date:  2022-01-23       Impact factor: 2.732

2.  Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017-2018.

Authors:  Zayd Adnan Razouki; Xiaotao Zhang; Jessica P Hwang; Natalia I Heredia
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

3.  Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Dig Dis Sci       Date:  2022-09-29       Impact factor: 3.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.